Medical News

RSS

Kaiser Permanente approves 500 grants and donations totaling $90M in fourth-quarter of 2009

Kaiser Permanente, one of America's leading health care providers and nonprofit health plans, announced today it approved 500 grants and donations nationwide totaling $90 million in the fourth quarter of 2009. In total, Kaiser Permanente approved $170 million in grants and donations to support efforts to keep people healthy during these tough economic times.

12 Feb 2010

KHN column -- Don't stop now: Lawmakers should pass the Senate bill

In her latest column for Kaiser Health News, Judy Feder writes: "Veterans of health reform battles know all too well that enacting health reform is as challenging to the nation's political system as it is important to the nation's well-being.

12 Feb 2010

Study: Hospitalizations for H1N1 differ from hospitalizations associated with typical flu

When compared to a typical flu, the H1N1 virus resulted in a higher proportion of patients requiring specialized hospital services - and affected younger people more - according to a new study released today by the Canadian Institute for Health Information (CIHI).

12 Feb 2010

Positive results from Shire's velaglucerase alfa Phase III study for Type 1 Gaucher disease

Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.

12 Feb 2010

Regence introduces Evolve to meet full spectrum of consumers' healthcare needs

Regence introduces Evolve, a new portfolio of individual health plans designed to meet the full spectrum of consumers' needs. From children needing preventative care, unemployed individuals seeking core coverage or a family searching for comprehensive benefits, Evolve has options to meet each unique situation.

12 Feb 2010

Routine testing of hs-CRP in women with heart disease is controversial, says Mayo Clinic cardiologist

For women concerned about heart disease, routine testing of high-sensitivity C-reactive protein (hs-CRP) is controversial, says Thomas Behrenbeck, M.D., Ph.D., a Mayo Clinic cardiologist, in an interview in the February issue of Mayo Clinic Women's HealthSource.

12 Feb 2010

Sustamine L-Alanyl-L-Glutamine supplement increases performance in endurance exercise and activity

A clinical study by Dr. Jay Hoffman, PhD, professor and chair of the Department of Health and Exercise Science at the College of New Jersey, has shown Sustamine™ L-Alanyl-L-Glutamine, increases performance in endurance exercise and activity. The study was published on February 3, 2010, in the Journal of the International Society of Sports Nutrition (JISSN), a peer-reviewed journal covering various aspects of sports nutrition, supplementation, exercise metabolism, and/or scientific policies related to sports nutrition.

12 Feb 2010

Heavy rains hit tent camps in Haiti

Heavy rains hit earthquake survivors in tent camps in Port-au-Prince on Thursday, "bringing a warning of fresh misery to come for the 1 million people living on the streets," Reuters reports.

12 Feb 2010

OrbusNeich commences enrollment in Chinese Genous Bio-engineered R stent trial

OrbusNeich today announced that the first patient has been enrolled in a randomized clinical trial of the Genous Bio-engineered R stent in China.

12 Feb 2010

CapitalBio officially joins Roche NimbleGen CSP Program

Roche NimbleGen announced today that Beijing-based genomic services provider CapitalBio has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.

12 Feb 2010

ASU scientists develop versatile DNA reader to unlock DNA genetic code

Arizona State University scientists have come up with a new twist in their efforts to develop a faster and cheaper way to read the DNA genetic code. They have developed the first, versatile DNA reader that can discriminate between DNA's four core chemical components⎯the key to unlocking the vital code behind human heredity and health.

12 Feb 2010

Proving value a challenge for comparative effectiveness and pharmaceutical technologies

The Wall Street Journal reports that "an examination of one of the best-known examples of a comparative-effectiveness analysis shows how complicated such a seemingly straightforward idea can get" as officials look for savings in the health care system." One study, called Courage, "found that the most common heart surgery -- a $15,000 procedure that unclogs arteries using a small scaffold or stent -- usually yields no additional benefit when used with a cocktail of generic drugs in patients suffering from chronic chest pain."

12 Feb 2010

AMC receives GWTG-Stroke Gold Performance Achievement Award for caring stroke patients

Adventist Medical Center recently received the American Heart Association/American Stroke Association's Get With The Guidelines (GWTG) - Stroke Gold Performance Achievement Award. The award recognizes AMC's commitment and success in implementing a higher standard of stroke care by ensuring that stroke patients receive treatment according to nationally accepted standards and recommendations provided by the AHA/ASA.

12 Feb 2010

NMDP Phase III filgrastim trial: Biologics to provide pharmacy management services

Biologics, Inc., the leading cancer management company in the United States, announces that its Oncology Clinical Trial Services division has been selected by the National Marrow Donor Program® (NMDP), a nonprofit organization that facilitates unrelated hematopoietic cell transplants.

12 Feb 2010

Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

XenaCare Holdings, Inc., a company specializing in the marketing and retail distribution of consumer healthcare products, announced today that it has begun distributing and selling Cobroxin through mass food and drug retail chains in the Northeast, Southeast, Middle Atlantic and Midwest regions.

12 Feb 2010

Ulcerative colitis drug market to grow up to $2.1 billion in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the ulcerative colitis drug market will nearly double from $1.2 billion in 2008 to $2.1 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

12 Feb 2010

Siemens Healthcare renews strategic alliance with NextGen Healthcare Information Systems

Today, Siemens Healthcare announced it has renewed its strategic alliance with NextGen Healthcare Information Systems to deliver innovative ambulatory information technology (IT) solutions. More than 35 Siemens customers have already deployed NextGen Healthcare's ambulatory IT tools throughout their physician networks as a result of the relationship, formed to offer healthcare providers interoperable solutions that cross the care coordination gap between the acute and ambulatory environments.

12 Feb 2010

Second-quarter fiscal 2010 results announced by Pharmacyclics

Pharmacyclics, Inc. today reported financial results for its second fiscal quarter ended December 31, 2009.

12 Feb 2010

Researchers identify potential drug candidate that halts tumor growth

A novel - and rapid - anti-cancer drug development strategy has resulted in a new drug that stops kidney and pancreatic tumors from growing in mice. Researchers at the Moores Cancer Center at the University of California, San Diego, have found a drug that binds to a molecular "switch" found in cancer cells and cancer-associated blood vessels to keep it in the "off" position.

12 Feb 2010

RTI Biologics supports Haiti relief efforts with Matrix HD sterilized dermis allografts donation

RTI Biologics Inc., the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated Matrix HD™ sterilized dermis allografts to use in limb salvage procedures for victims of the recent natural disasters in Haiti.

12 Feb 2010

Medical News

Kaiser Permanente approves 500 grants and donations totaling $90M in fourth-quarter of 2009

KHN column -- Don't stop now: Lawmakers should pass the Senate bill

Study: Hospitalizations for H1N1 differ from hospitalizations associated with typical flu

Positive results from Shire's velaglucerase alfa Phase III study for Type 1 Gaucher disease

Regence introduces Evolve to meet full spectrum of consumers' healthcare needs

Routine testing of hs-CRP in women with heart disease is controversial, says Mayo Clinic cardiologist

Sustamine L-Alanyl-L-Glutamine supplement increases performance in endurance exercise and activity

Heavy rains hit tent camps in Haiti

OrbusNeich commences enrollment in Chinese Genous Bio-engineered R stent trial

CapitalBio officially joins Roche NimbleGen CSP Program

ASU scientists develop versatile DNA reader to unlock DNA genetic code

Proving value a challenge for comparative effectiveness and pharmaceutical technologies

AMC receives GWTG-Stroke Gold Performance Achievement Award for caring stroke patients

NMDP Phase III filgrastim trial: Biologics to provide pharmacy management services

Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

Ulcerative colitis drug market to grow up to $2.1 billion in 2018

Siemens Healthcare renews strategic alliance with NextGen Healthcare Information Systems

Second-quarter fiscal 2010 results announced by Pharmacyclics

Researchers identify potential drug candidate that halts tumor growth

RTI Biologics supports Haiti relief efforts with Matrix HD sterilized dermis allografts donation

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News